Free Trial

Bessemer Group Inc. Has $132,000 Holdings in TriMas Corporation (NASDAQ:TRS)

TriMas logo with Industrials background

Bessemer Group Inc. cut its stake in shares of TriMas Corporation (NASDAQ:TRS - Free Report) by 66.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,645 shares of the industrial products company's stock after selling 11,340 shares during the period. Bessemer Group Inc.'s holdings in TriMas were worth $132,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in TriMas by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company's stock valued at $95,801,000 after acquiring an additional 82,068 shares during the period. Bank of America Corp DE grew its stake in TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after acquiring an additional 1,967,738 shares during the period. Medina Value Partners LLC grew its stake in TriMas by 2.9% in the fourth quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company's stock valued at $25,448,000 after acquiring an additional 28,851 shares during the period. Advisory Research Inc. grew its stake in TriMas by 41.2% in the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock valued at $18,543,000 after acquiring an additional 220,000 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in TriMas by 3.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 605,502 shares of the industrial products company's stock valued at $14,889,000 after acquiring an additional 22,656 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have issued reports on TRS. Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. BWS Financial reaffirmed a "buy" rating and set a $40.00 price objective on shares of TriMas in a research report on Wednesday, April 30th.

Read Our Latest Report on TriMas

Insider Transactions at TriMas

In related news, Director Adrianne Shapira purchased 4,000 shares of the business's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $25.82 per share, for a total transaction of $103,280.00. Following the purchase, the director owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Shawn Sedaghat bought 72,937 shares of the business's stock in a transaction dated Thursday, May 22nd. The stock was acquired at an average price of $26.16 per share, for a total transaction of $1,908,031.92. Following the purchase, the director directly owned 1,883,758 shares in the company, valued at approximately $49,279,109.28. The trade was a 4.03% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 971,649 shares of company stock valued at $24,585,343 over the last ninety days. 14.20% of the stock is currently owned by corporate insiders.

TriMas Price Performance

NASDAQ:TRS opened at $29.97 on Friday. The company has a quick ratio of 1.49, a current ratio of 2.82 and a debt-to-equity ratio of 0.63. The stock's 50 day moving average price is $26.04 and its two-hundred day moving average price is $24.22. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of 38.92 and a beta of 0.63. TriMas Corporation has a 12-month low of $19.33 and a 12-month high of $30.12.

TriMas (NASDAQ:TRS - Get Free Report) last posted its earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.43 by $0.03. The company had revenue of $241.67 million for the quarter, compared to the consensus estimate of $235.41 million. TriMas had a return on equity of 10.54% and a net margin of 3.36%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.37 earnings per share. On average, analysts anticipate that TriMas Corporation will post 1.69 earnings per share for the current year.

TriMas Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date was Tuesday, May 6th. TriMas's payout ratio is 20.78%.

TriMas Company Profile

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Recommended Stories

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRS - Free Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines